Your browser doesn't support javascript.
loading
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
Pauli, Chantal; Hopkins, Benjamin D; Prandi, Davide; Shaw, Reid; Fedrizzi, Tarcisio; Sboner, Andrea; Sailer, Verena; Augello, Michael; Puca, Loredana; Rosati, Rachele; McNary, Terra J; Churakova, Yelena; Cheung, Cynthia; Triscott, Joanna; Pisapia, David; Rao, Rema; Mosquera, Juan Miguel; Robinson, Brian; Faltas, Bishoy M; Emerling, Brooke E; Gadi, Vijayakrishna K; Bernard, Brady; Elemento, Olivier; Beltran, Himisha; Demichelis, Francesca; Kemp, Christopher J; Grandori, Carla; Cantley, Lewis C; Rubin, Mark A.
Affiliation
  • Pauli C; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Hopkins BD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Prandi D; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Shaw R; Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Fedrizzi T; Center for Integrative Biology, University of Trento, Trento, Italy.
  • Sboner A; Cure First and SEngine Precision Medicine, Seattle, Washington.
  • Sailer V; Center for Integrative Biology, University of Trento, Trento, Italy.
  • Augello M; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Puca L; Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Rosati R; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.
  • McNary TJ; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Churakova Y; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Cheung C; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Triscott J; Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Pisapia D; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Rao R; Cure First and SEngine Precision Medicine, Seattle, Washington.
  • Mosquera JM; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Robinson B; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Faltas BM; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Emerling BE; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Gadi VK; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Bernard B; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Elemento O; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Beltran H; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Demichelis F; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Kemp CJ; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Grandori C; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
  • Cantley LC; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Rubin MA; Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York.
Cancer Discov ; 7(5): 462-477, 2017 05.
Article in En | MEDLINE | ID: mdl-28331002

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Screening Assays, Antitumor / Organoids / Xenograft Model Antitumor Assays / Precision Medicine / Exome Sequencing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Discov Year: 2017 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Screening Assays, Antitumor / Organoids / Xenograft Model Antitumor Assays / Precision Medicine / Exome Sequencing Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Discov Year: 2017 Document type: Article Country of publication: United States